BD to Present at Investor Healthcare Conferences

FRANKLIN LAKES, N.J., May 15, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Bank of America Merrill Lynch 2017 Healthcare Conference  May 17, 2017 11:40 a.m. EDT Jefferies 2017 Global Healthcare Conference June 8, 2017 9:00 a.m.... Read more

Agilent Technologies Announces Expanded Use for PD-L1 IHC 28-8 pharmDx Diagnostic in Europe

Approved for Use in Europe to Identify Head and Neck Cancer Patients Most Likely to Benefit from Opdivo (nivolumab) Therapy SANTA CLARA, Calif., May 15, 2017 Agilent Technologies Inc. (NYSE: A) today announced the expanded use of Agilent’s Dako PD-L1 IHC 28-8 pharmDx test for squamous cell carcinoma of the head and neck (SCCHN), the... Read more

“Hitachi High Tech Science Park” to Open in California

Chatsworth, California, May 15, 2017 – Hitachi High Technologies America, Inc. (HTA), an American subsidiary of Hitachi High-Technologies Corporation (TOKYO: 8036, Hitachi High-Tech), announces that it will open “Hitachi High Tech Science Park” in Chatsworth, California, on June 9, 2017, to work more closely with Hitachi High-Tech’s Scientific Systems Business (including, for example, electron microscopes)... Read more

Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 11 May 2017 Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting 20 Roche medicines are included in more than 190 abstracts during ASCO 2017 New pivotal results for Perjeta (pertuzumab) and Alecensa (alectinib) improve upon standards of care   Early... Read more

Danaher To Present At Bank Of America Merrill Lynch Health Care Conference

WASHINGTON, May 10, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 17, 2017 at 9:20 a.m. PT. The audio will be simultaneously webcast on www.danaher.com. ... Read more

Roche launches AVENIO ctDNA Analysis Kits for Oncology Research

Basel, 08 May 2017 Roche launches AVENIO ctDNA Analysis Kits for Oncology Research First blood-based distributed oncology tests covering all four mutation classes Three test choices provide accurate insights into different stages and types of cancer Streamlined testing generates results in five days Roche (SIX: RO, ROG; OTCQX:RHHBY) today announced the global commercial launch of... Read more

Brooks Life Science Systems Launches its BioStudiesTM Biobank Data Management System with Built-in Data Visualization Capabilities from MicroStrategy

Life Science companies, academic research institutions and biobanks can now achieve comprehensive visualization of biobank sample collection data with disparate databases Chelmsford, Mass. May 8, 2017 – Brooks Life Science Systems (Brooks) is launching its newest informatics platform, BioStudiesTM, to provide the industry’s most comprehensive purpose-built sample intelligence software system integrated with market leading enterprise... Read more

Gyros Protein Technologies appoints Mark Vossenaar as Vice President, European Sales

Uppsala, Sweden, 4 May, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Mark Vossenaar as Vice President Sales, Europe, effective immediately. Mr. Vossenaar brings more than 25 years of experience in developing and leading life and health science commercial... Read more

Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more